MedPath

The Antidepressant Effect of Right Temporal Low Frequency rTMS Compared to Sham

Not Applicable
Terminated
Conditions
Depressive Disorder
Interventions
Procedure: right temporal low frequency (1 hz) rTMS
Procedure: Sham-rTMS
Registration Number
NCT00622947
Lead Sponsor
University of Aarhus
Brief Summary

The aim of the present study is to compare the antidepressant effect of low frequency rTMS applied over the right temporal cortex with sham stimulation.

Detailed Description

TMS complies focal stimulation of the brain through a time varying magnetic field. Clinical controlled trials indicate that rTMS of the dorsolateral prefrontal cortex may have an antidepressant effect and no serious side effects. Several clinical controlled studies investigating the antidepressant effect of low as well as high frequency rTMS of the right and left prefrontal cortex have been carried out with varying results.Research on the issue suffer from small and selected study populations.There is a need for additional clinical controlled studies on larger samples and methodological investigations to clarify what is the optimal stimulus design for the treatment of depressed patients.

Recent research indicates that Depression is associated with an increased metabolic activity of subcortical areas especially the right hippocampus of the brain.

Remission of depression symptoms is associated with normalisation of the described subcortical hyperactivity.

Low frequency rTMS has shown to be associated with sustained reduction in neuronal activity.

There may be an association between the activity decreasing effect of low frequency rTMS and reduction in psychiatric symptoms.

The investigators want to test the hypothesis that low frequency rTMS of the right temporal subcortical areas (Hippocampus and and the parahippocampal part of CNS) may perform an antidepressant effect by normalizing the described hyperactivity of the subcortical areas in depressed patients.

In addition the investigators want to test whether blood concentration of Brain Derived Neurotropic Factor( BDNF), the BDNF-genotype and saliva cortisol may be of predictive value in depressed patients.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Inpatients admitted to Århus university Hospital , Risskov or outpatients from the psychiatry district centres or practising specialist in the area.
  • Moderate - severe depression according to ICD-10/ DSM-IVR
  • Age 18-80 years
  • Total Hamilton score ( 17-items) of ≥ 18 or subscale score ≥ 9
  • Right handed
Exclusion Criteria
  • Organic brain disease
  • Epilepsy in growing age
  • Metallic objects as the result of a chest or Brain surgery
  • Cardiac pacemakers
  • Somatic diseases associated with brain dysfunction
  • Pregnancy
  • Suicide risk of severe degree
  • Severe agitation or delirium
  • Alcohol and drug dependency
  • Ongoing Electroconvulsive treatment

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
repetitive transcranial magnetic stimulationright temporal low frequency (1 hz) rTMSLow frequency ( 1 HZ) rTMS of the right prefrontal cortex. On each of 15 consecutive week days (apart from weekends), the patients received two 60-second1-Hz trains delivered at an intensity of 110% of motor thresholdand with a 180 seconds' intertrain interval.
Placebo stimulationSham-rTMSSham- rTMS of the right prefrontal cortex. On each of 15 consecutive week days (apart from weekends), the patients received two 60-second1-Hz trains delivered at an intensity of 110% of motor thresholdand with a 180 seconds' intertrain interval.
Primary Outcome Measures
NameTimeMethod
The total 17-item score on the Hamilton scale for depression4 weeks of treatment and 4 weeks of follow-up

semistructured interview scale.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Hospital of Aarhus, Risskov

🇩🇰

Aarhus, Risskov, Denmark

© Copyright 2025. All Rights Reserved by MedPath